Home > Insider Trading > Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc. (CPRX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
41 - 50
Next >>

Catalyst Pharmaceuticals Inc (CPRX) Isn't Out Of The Woods With Firdapse Just Yet

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) just announced that it is carrying forward with a special protocol assessment (SPA) for its lead asset, Firdapse, for the treatment of Lambert-Eaton myasthenic...

Keep Reading →

November 1st, 2016 - News Stock Analysis

Here's Why Catalyst Pharmaceuticals, Resolute Energy, Nutanix & Two Other Stocks Are Trading Higher Today

The markets have shaken off their negative trend as major indices are trading in the green zone.

Keep Reading →

October 5th, 2016 - Market Movers News

What We’re Looking For From The Catalyst Pharmaceuticals Inc (CPRX) Data

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) just reported that the FDA has granted Orphan Drug Designation to its lead development candidate, and the company is up nearly 10% on the news.

Keep Reading →

September 6th, 2016 - News Stock Analysis

Noteworthy Insider Transactions at 5 Companies Amid Slowing Insider Buying as Markets Near All-Time Highs

Investors usually associate insider trading with illegal conduct, but not all insider trading activity is illegal. In fact, most corporate insiders buy and sell securities in a perfectly legal way.

Keep Reading →

July 13th, 2016 - Insider Trading News

Most Popular Healthcare Penny Stocks Among Hedge Funds

Although a great movie, The Wolf of Wall Street left many people thinking penny stocks are somewhat 'untouchable'.

Keep Reading →

June 9th, 2016 - Hedge Funds News

What Has Investors Spooked About These 5 Stocks Today?

Although all three indexes are in the green and crude futures are 2% higher, shares of Capital Product Partners L.P. (NASDAQ:CPLP), Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Nabors Industries Ltd.

Keep Reading →

April 26th, 2016 - Market Movers News

Insider Buying Points To Huge Upside For These 3 Beaten-Down Stocks

Rising interest rates, a struggling Chinese economy, declining crude oil prices and a strong U.S dollar are key factors that explain the increased volatility and wild swings in the U.S equity market...

Keep Reading →

January 13th, 2016 - Insider Trading News

Hedge Funds Are Dumping Catalyst Pharmaceutical Partners, Inc. (CPRX)

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.

Keep Reading →

November 25th, 2015 - Hedge Funds News

Is Catalyst Pharmaceutical Partners, Inc. (CPRX) a "Buy" after Its Promising Results In Proof-Of-Concept Trial Of Vigabatrin

Earlier today Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) has announced promising top-line results in proof-of-concept trial of its CPP-109 (Vigabatrin).

Keep Reading →

June 24th, 2015 - Hedge Funds News

Catalyst Pharmaceutical Partners, Inc. (CPRX): Steven Cohen Bets on Another Biotech Development-Stage Stock

In a new filing with the Securities and Exchange Commission, Steven Cohen's Point72 Asset Management disclosed a new stake in Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX).

Keep Reading →

December 3rd, 2014 - Hedge Funds News